Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans

Journal of General Internal Medicine

Volumn 30, Issue 11, 2015, Pages 1591-1598

  Voils, Corrine I ^a,b   Coffman, Cynthia J ^a,b   Grubber, Janet M ^a   Edelman, David ^a,b   Sadeghpour, Azita ^b   Maciejewski, Matthew L ^a,b   Bolton, Jamiyla ^a   Cho, Alex ^b   Ginsburg, Geoffrey S ^b,c   Yancy, William S ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Center for Personalized and Precision Medicine   (United States)

Author keywords

Diabetes mellitus; Genetic counseling; Risk factors

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; EDUCATIONAL STATUS; FAMILY HISTORY; FAT INTAKE; FEMALE; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HEALTH CARE COST; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VETERAN; WALKING; COMPLICATION; COUNSELING; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION; GENETICS; HEALTH BEHAVIOR; LIFESTYLE; MIDDLE AGED; NORTH CAROLINA; OBESITY; PROCEDURES; PSYCHOLOGY; RISK REDUCTION; WEIGHT REDUCTION; YOUNG ADULT;

ADULT; AGED; COUNSELING; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NORTH CAROLINA; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); OVERWEIGHT; RISK FACTORS; RISK REDUCTION BEHAVIOR; VETERANS; WEIGHT LOSS; YOUNG ADULT;

EID: 84945491693     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-015-3315-5     Document Type: Article

References (38)

1. Adriaanse MC, Snoek FJ, Dekker JM, et al. Perceived risk for Type 2 diabetes in participants in a stepwise population-screening programme. Diabet Med. 2003;20:210–215.
2. Wee H-L, Cheung Y-B, Li S-C, Fong K-Y, Thumboo J. The impact of diabetes mellitus and other chronic medical conditions on health-related Quality of Life: Is the whole greater than the sum of its parts? Health Qual Life Outcome. 2005;3:2.
3. Engelgau MM, Geiss LS, Saaddine JB, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140:945–950.
4. Centers for Disease Control and Prevention: National Diabetes Fact Sheet, 2011, Fact Sheet. Atlanta, GA: Department of Health and Human Services - Center for Disease Control and Prevention, 2011.
5. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
6. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29:2102–2107.
7. Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–1686.
8. Janz NK, Becker MH. The Health Belief Model: A decade later. Health Educ Q. 1984;11:1–47.
9. Weinstein N. What does it mean to understand a risk? Evaluation risk comprehension. J Natl Cancer Inst Monogr. 1999;25:15–12.
10. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981–990.
11. Hivert MF, Jablonski KA, Perreault L, et al. Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes. 2011;60:1340–1348.
12. Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006;355:241–250.
13. Voils CI, Coffman CJ, Edelman D, et al. Examining the impact of genetic testing for type 2 diabetes on health behaviors: Study protocol for a randomized controlled trial. Trials. 2012;13:121.
14. Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–1395.
15. Block G: Block Brief 2000 Questionnaire, 2000.
16. Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30:1562–1566.
17. Hariri S, Yoon P, Qureshi N, et al. Family history of type 2 diabetes: A population-based screening tool for prevention? Genet Med. 2006;8:102–108.
18. Weedon MN, McCarthy MI, Hitman G, et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med. 2006;3:e374.
19. Lyssenko V, Laakso M. Genetic screening for the risk of type 2 diabetes: Worthless or valuable? Diabetes Care. 2013;36:S120–S126.
20. Fagerlin A, Zikmund-Fisher B, Ubel PA. Helping patients decide: Ten steps to better risk communication. J Natl Cancer Inst. 2011;103:1–8.
21. Nelson W, Reyna VF, Fagerlin A, Lipkus I, Peters E. Clinical implications of numeracy: Theory and practice. Ann Behav Med. 2008;35:261–274.
22. US Department of Health and Human Services: 2008 Physical Activity Guidelines for Americans, 2008.
23. Kahwati LC, Lance TX, Jones KR, Kinsinger LS. RE-AIM evaluation of the Veterans Health Administration’s MOVE! weight management program. Transl Behav Med. 2011;1:551–560.
24. Borm G, Fransen J, Lemmens W. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007;60:1234–1238.
25. Yancy W Jr, Westman E, McDuffie J, et al. A randomized trial of a low-carbohydrate, ketogenic diet versus orlistat plus a low-fat diet for weight loss. Arch Intern Med. 2010;170:136–145.
26. Lindstrom J, Louheranta A, Mannelin M, et al. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26:3230–3236.
27. Group IEEW. ICH harmonised tripartite guideline-Statistical principles for clinical trials. Stat Med. 1999;18:1905–1942.
28. Verbeke G, Molenbergh G. Linear mixed models for longitudinal data. New York: Springer-Verlag; 2000.
29. Fitzmaurice G, Laird N, Ware J. Applied Longitudinal Analysis. Hoboken, NJ: Wiley; 2004.
30. Diggle PJ, Heagerty P, Liang K, Zeger SL. Analysis of longitudinal data. New York: Oxford University Press; 2002.
31. Jensen MD, Ryan DH, Apovian CM, et al. AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2013;2014(129):S102–138.
32. Lewis A, Jolly K, Adab P, et al. A brief intervention for weight management in primary care: study protocol for a randomized controlled trial. Trials. 2013;14:393.
33. Grant RW, O’Brien KE, Waxler JL, et al. Personalized genetic risk counseling to motivate diabetes prevention: A randomized trial. Diabetes Care. 2013;36:13–19.
34. Vorderstrasse AA, Cho A, Voils CI, Orlando LA, Ginsburg GS. Clinical utility of genetic testing in primary care: The example of type 2 diabetes. Per Med. 2013;10:549–563.
35. Marteau TM, Weinman J. Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research. Soc Sci Med. 2006;62:1360–1368.
36. Vassy JL, Shrader P, Jonsson A, et al. Association between parental history of diabetes and type 2 diabetes genetic risk scores in the PPP-Botnia and Framingham Offspring Studies. Diabetes Res Clin Pract. 2011;93:e76–79.
37. de Miguel-Yanes JM, Shrader P, Pencina MJ, et al. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. Diabetes Care. 2011;34:121–125.
38. Rubin DB. Inference and missing data. Biometrika. 1976;63:581–592.